| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | — |
| Cost of Revenue | $3.8M | — |
| R&D Expense | $11.8M | -24.0% |
| SG&A Expense | $53.4M | +158.8% |
| Operating Income | -$55.4M | -53.2% |
| Interest Expense | $8.1M | +146.0% |
| Income Tax | $0 | — |
| Net Income | -$54.8M | -48.8% |
| EPS (Basic) | -$1.42 | -9.2% |
| EPS (Diluted) | -$1.42 | -9.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.8M | -34.1% |
| Short-term Investments | $29.2M | -38.0% |
| Accounts Receivable | $4.5M | — |
| Inventory | $8.8M | +618.7% |
| Current Assets | $92.9M | -24.6% |
| Total Assets | $94.5M | -23.9% |
| Current Liabilities | $13.1M | +77.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.2M | -71.3% |
| Capital Expenditures | $40K | +90.5% |
| Investing Cash Flow | $20.0M | +143.5% |
| Financing Cash Flow | $14.8M | -80.8% |
| Free Cash Flow | -$59.3M | -71.4% |
| Long-term Debt |
| $38.8M |
| +5.5% |
| Total Liabilities | $57.3M | +10.6% |
| Stockholders' Equity | $37.2M | -48.6% |